From laboratory of Biotherapy, National Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan university, Renmin Nanlu 17, Chengdu, 610041, Sichuan, China.
Signal Transduct Target Ther. 2022 Apr 20;7(1):108. doi: 10.1038/s41392-022-00936-w.
Large scale genomic aberrations including duplication, deletion, translocation, and other structural changes are the cause of a subtype of hereditary genetic disorders and contribute to onset or progress of cancer. The current prime editor, PE2, consisting of Cas9-nickase and reverse transcriptase enables efficient editing of genomic deletion and insertion, however, at small scale. Here, we designed a novel prime editor by fusing reverse transcriptase (RT) to nuclease wild-type Cas9 (WT-PE) to edit large genomic fragment. WT-PE system simultaneously introduced a double strand break (DSB) and a single 3' extended flap in the target site. Coupled with paired prime editing guide RNAs (pegRNAs) that have complementary sequences in their 3' terminus while target different genomic regions, WT-PE produced bi-directional prime editing, which enabled efficient and versatile large-scale genome editing, including large fragment deletion up to 16.8 megabase (Mb) pairs and chromosomal translocation. Therefore, our WT-PE system has great potential to model or treat diseases related to large-fragment aberrations.
大规模基因组结构异常,包括重复、缺失、易位和其他结构改变,是遗传性遗传疾病亚类的病因,并导致癌症的发生或进展。当前的主要编辑器 PE2 由 Cas9 核酸酶和逆转录酶组成,可实现基因组缺失和插入的高效编辑,但规模较小。在这里,我们通过将逆转录酶 (RT) 融合到核酸酶野生型 Cas9 (WT-PE) 中设计了一种新型的主要编辑器,以编辑大片段基因组。WT-PE 系统同时在靶位点处引入双链断裂 (DSB) 和单个 3' 延伸的小瓣。与靶向不同基因组区域但在其 3' 末端具有互补序列的成对的主编辑引导 RNA (pegRNA) 结合使用,WT-PE 产生双向主编辑,从而实现高效和多功能的大规模基因组编辑,包括长达 16.8 兆碱基对 (Mb) 的大片段缺失和染色体易位。因此,我们的 WT-PE 系统具有很大的潜力来模拟或治疗与大片段异常相关的疾病。